MarketPulse
E

$EVO

2 articles found
1 positive
1 negative
0 neutral
BenzingaBenzinga··Vandana Singh

Gilead Bolsters Oncology Arsenal With $3B Tubulis Acquisition

Gilead acquires Tubulis for $3.15 billion including milestones, adding HER2-targeting ovarian cancer candidate to oncology pipeline—second major deal in months.
GILDACLXEVOacquisitionbiotech
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Legal Probe Into Evotec's €700M Revenue Guidance and Restructuring Charges

Johnson Fistel investigates whether Evotec disclosed material information about its March 2026 Horizon restructuring, which included €100M in charges and revised revenue guidance.
EVOinvestor lossessecurities investigation